Navigation Links
Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results
Date:8/9/2013

BLUE BELL, Pa., Aug. 9, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended June 30, 2013.

Total revenue was $786,000 and $2.2 million for the three and six months ended June 30, 2013, compared to $436,000 and $2.1 million for the same periods in 2012.

Total operating expenses were $6.5 million and $14.5 million for the three and six months ended June 30, 2013, compared to $7.2 million and $13.1 million for the same periods in 2012.

The net loss attributable to common stockholders for the three and six months ended June 30, 2013, was $10.9 million, or $0.06 per share, and $19.7 million, or $0.12 per share, as compared with a net loss attributable to common stockholders of $4.1 million, or $0.03 per share, and $12.4 million, or $0.09 per share, for the three and six months ended June 30, 2012.

Revenue The increase in revenue for the comparable periods was primarily due to higher revenue recognized from our PATH Malaria Vaccine Initiative ("MVI") grant as well as an increase in revenue from our U.S. Department of Defense Small Business Innovation Research Grant and our grant subcontract with the University of Pennsylvania. The variance is also due to the timing of work performed under the company's contract with the National Institute of Allergy and Infectious Diseases (NIAID). This NIAID contract, which provides up to $25.3 million of funding over seven years, is facilitating Inovio's development of a universal, preventive HIV DNA vaccine, PENNVAX®-GP.

Operating Expenses Research and development expenses for the three and six months ended June 30, 2013 were $4.4 million and $9.5 million, compared to $4.5 million and $8.6 million for the same periods in 2012. The increase for the six month period was primarily due to $520,000 in higher clinical expenses related to our ongoing HPV-003 phase II clinical trial. General and administrative expenses for the thr
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Inovio Pharmaceuticals Responds to Market Activity
2. Inovio Pharmaceuticals Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence
3. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
4. Todays Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
5. Inovio Pharmaceuticals to Present at OneMedForumNY 2013 Investor Conference
6. Inovios Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals
7. Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
8. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
9. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
10. Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
11. Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... DUBLIN , Sept. 23, 2014 /PRNewswire/ ... "Company"), a biotechnology company pioneering the manufacturing and ... emerging nations, today announced that the Depository Trust ... DTC,s Deposit and Withdrawal at Custodian ("DWAC") service ... transfer agent as the distribution point.  The Company,s ...
(Date:9/23/2014)... -- This test can detect HIV infection if used 3 ... activities that can transfer body fluids from one person to ... needles. , An in-vitro diagnostic home-use test for ... works by looking for your body,s response to fighting the ... patients to learn their status in a single visit and ...
(Date:9/23/2014)... DUBLIN , September 23, 2014 /PRNewswire/ ... ) has announced the addition of the  ...  report to their offering.  ... injectable drug delivery market holds significant potential ... with vials and painful needles to the ...
Breaking Medicine Technology:TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4WholeHealth Products announces the release of the FDA Cleared "HIV 1&2" Rapid Diagnostic Test for Professional and Retail 2Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5
... N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Nymox,Pharmaceutical Corporation ... the Company's recently completed studies of,NX-1207 for ... at,a series of upcoming U.S. urology meetings, ... Urological Association Meeting in,Colorado Springs. These independent ...
... June 21, 2007 /PRNewswire/ -- , What and When , Data ... presented in poster format at the 67th,Scientific Sessions of the American ... serious adverse events in high-risk type 2, ... from, PROactive; Poster 0553-P presented ...
Cached Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 3
(Date:9/23/2014)... Doheny HealthDay Reporter TUESDAY, ... very low birth weights, breast milk is more likely than ... known as cytomegalovirus (CMV), a new study finds. The ... -- all of whom weighed 3.3 pounds or less and ... CMV infection, to see whether breast milk or transfusions carried ...
(Date:9/23/2014)... drinking and getting drunk at an early age are ... students, a new study suggests. The conclusions, based ... could help expand alcohol-prevention efforts aimed at teens to ... becoming binge drinkers, the researchers suggested. , , "Efforts ... progression to first heavy use as risk factors for ...
(Date:9/23/2014)... What information do patients need ... Forum (NQF) released a report ( http://bit.ly/1DwekE9 ), ... infographic ( http://bit.ly/1tX3lzA ) resulting from an in-depth ... patients define affordability, and what information and changes ... possible healthcare at the lowest possible cost. ...
(Date:9/23/2014)... 23, 2014 (HealthDay News) -- Few children ... undergo behavioral therapy, and the rates vary six-fold ... study finds. Medication alone can manage symptoms ... better if they also receive behavioral therapy (psychotherapy), ... analyzed data in more than 1,500 counties across ...
(Date:9/23/2014)... grow up to earn up to 18 percent less ... Lundborg of Lund University, Paul Nystedt of Jnkping University ... all in Sweden. The team compared extensive information from ... the results are published in Springer,s journal Demography ... 145,193 Swedish-born brothers who enlisted in the Swedish National ...
Breaking Medicine News(10 mins):Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Note to young men: Fat doesn't pay 2
... evidence of the damaging impact of marijuana on humans ... symptoms in some people, including hallucinations and paranoid delusions, ... recent study, one compound, cannabidiol, or CBD, made people ... tetrahydrocannabinol, or THC, produced temporary psychotic symptoms in people, ...
... victims of a bite from the Brazilian wandering spider (Phoneutria ... in blood pressure, they also sport an uncomfortable erection. ,And ... Viagras. Scientists say they have figured out the chemical that ... , “The erection is a side effect that everybody who ...
... healthcare scheme proposed by the Australian Federal government. The ... people to opt for private health insurance; yet this plan ... by public hospital, a report has shown. ,Dr ... Research on Health, explained the benefits of doing away with ...
... affect people of all ages. The general public is at ... instruction on ladder use and safety. ,According to ... Journal of Preventive Medicine and conducted by the Center for ... than 2.1 million individuals were treated in U.S. emergency departments ...
... suffer migraine attacks, beware. Recent research has shown the ... depression and suicidal tendencies. They could also be suffering ... ,Teens suffering migraines are prone to depressive tendencies ... such agonizing headaches, a new study has shown. ...
... homes have started coming to the fore. One among fifty ... review by the Department of Ageing, Disability and Home Care, ... involving abuse and lack of care. The main cause was ... carers. ,Advocates nationwide say it is a growing problem ...
Cached Medicine News:Health News:Marijuana can Trigger Psychotic Symptoms, New Study Finds 2Health News:Brazil Spider Offers Hope for Those Suffering from Erectile Dysfunction 2Health News:$3bn Rebate Scheme – Is Australia Making a Prudent Move 2Health News:Ladder-related Injuries on the Rise in U.S 2Health News:Link Between Migraine Attacks in Teens and Suicidal Tendencies 2Health News:Abuse of the Disabled in Government Run Homes 2
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
... The Research Family includes fixed-volume, ... as the electronic Eppendorf Research pro ... button, these compact, high-performance pipettes have ... Optimally suited for use with original ...
10L...
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
Medicine Products: